Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.
2.

Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation.

Haglund K, Schmidt MH, Wong ES, Guy GR, Dikic I.

EMBO Rep. 2005 Jul;6(7):635-41.

3.

Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex.

Schmidt MH, Hoeller D, Yu J, Furnari FB, Cavenee WK, Dikic I, Bögler O.

Mol Cell Biol. 2004 Oct;24(20):8981-93.

4.

Identification of a novel proline-arginine motif involved in CIN85-dependent clustering of Cbl and down-regulation of epidermal growth factor receptors.

Kowanetz K, Szymkiewicz I, Haglund K, Kowanetz M, Husnjak K, Taylor JD, Soubeyran P, Engstrom U, Ladbury JE, Dikic I.

J Biol Chem. 2003 Oct 10;278(41):39735-46. Epub 2003 Jul 21.

5.

SH3KBP1-binding protein 1 prevents epidermal growth factor receptor degradation by the interruption of c-Cbl-CIN85 complex.

Feng L, Wang JT, Jin H, Qian K, Geng JG.

Cell Biochem Funct. 2011 Oct;29(7):589-96. doi: 10.1002/cbf.1792. Epub 2011 Aug 9.

6.

Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors.

Soubeyran P, Kowanetz K, Szymkiewicz I, Langdon WY, Dikic I.

Nature. 2002 Mar 14;416(6877):183-7. Erratum in: Nature 2002 May 2;417(6884):102.

PMID:
11894095
7.

The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor.

Lill NL, Douillard P, Awwad RA, Ota S, Lupher ML Jr, Miyake S, Meissner-Lula N, Hsu VW, Band H.

J Biol Chem. 2000 Jan 7;275(1):367-77.

10.

CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases.

Szymkiewicz I, Kowanetz K, Soubeyran P, Dinarina A, Lipkowitz S, Dikic I.

J Biol Chem. 2002 Oct 18;277(42):39666-72. Epub 2002 Aug 12.

11.

Cbl-family ubiquitin ligases and their recruitment of CIN85 are largely dispensable for epidermal growth factor receptor endocytosis.

Ahmad G, Mohapatra BC, Schulte NA, Nadeau SA, Luan H, Zutshi N, Tom E, Ortega-Cava C, Tu C, Sanada M, Ogawa S, Toews ML, Band V, Band H.

Int J Biochem Cell Biol. 2014 Dec;57:123-34. doi: 10.1016/j.biocel.2014.10.019. Epub 2014 Oct 23.

12.

Cloning and characterization of a novel adaptor protein, CIN85, that interacts with c-Cbl.

Take H, Watanabe S, Takeda K, Yu ZX, Iwata N, Kajigaya S.

Biochem Biophys Res Commun. 2000 Feb 16;268(2):321-8.

PMID:
10679202
13.

Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development.

Meisner H, Daga A, Buxton J, Fernández B, Chawla A, Banerjee U, Czech MP.

Mol Cell Biol. 1997 Apr;17(4):2217-25.

14.

Coupling of the proto-oncogene product c-Cbl to the epidermal growth factor receptor.

Meisner H, Czech MP.

J Biol Chem. 1995 Oct 27;270(43):25332-5.

16.

Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases.

Kowanetz K, Crosetto N, Haglund K, Schmidt MH, Heldin CH, Dikic I.

J Biol Chem. 2004 Jul 30;279(31):32786-95. Epub 2004 May 24.

17.
18.

Cbl-dependent ubiquitination is required for progression of EGF receptors into clathrin-coated pits.

Stang E, Blystad FD, Kazazic M, Bertelsen V, Brodahl T, Raiborg C, Stenmark H, Madshus IH.

Mol Biol Cell. 2004 Aug;15(8):3591-604. Epub 2004 Jun 11.

19.

Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors.

Haglund K, Shimokawa N, Szymkiewicz I, Dikic I.

Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12191-6. Epub 2002 Sep 6.

Supplemental Content

Support Center